Search Results - "Bela Sarmento‐Ribeiro, Ana"

Refine Results
  1. 1

    Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance by Alves, Raquel, Gonçalves, Ana Cristina, Rutella, Sergio, Almeida, António M., De Las Rivas, Javier, Trougakos, Ioannis P., Sarmento Ribeiro, Ana Bela

    Published in Cancers (26-09-2021)
    “…Resistance to targeted therapies is a complex and multifactorial process that culminates in the selection of a cancer clone with the ability to evade…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Zinc: From Biological Functions to Therapeutic Potential by Costa, Maria Inês, Sarmento-Ribeiro, Ana Bela, Gonçalves, Ana Cristina

    “…The trace element zinc (Zn) displays a wide range of biological functions. Zn ions control intercellular communication and intracellular events that maintain…”
    Get full text
    Journal Article
  14. 14

    The multi-factorial nature of clinical multidrug resistance in cancer by Assaraf, Yehuda G., Brozovic, Anamaria, Gonçalves, Ana Cristina, Jurkovicova, Dana, Linē, Aija, Machuqueiro, Miguel, Saponara, Simona, Sarmento-Ribeiro, Ana Bela, Xavier, Cristina P.R., Vasconcelos, M. Helena

    Published in Drug resistance updates (01-09-2019)
    “…Curative cancer therapy remains a major challenge particularly in cancers displaying multidrug resistance (MDR). The MDR phenotype is characterized by…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies by Pérez-Ruiz, Elisabeth, Melero, Ignacio, Kopecka, Joanna, Sarmento-Ribeiro, Ana Bela, García-Aranda, Marilina, De Las Rivas, Javier

    Published in Drug resistance updates (01-12-2020)
    “…Cancer is one of the main public health problems in the world. Systemic therapies such as chemotherapy and more recently target therapies as well as…”
    Get full text
    Journal Article
  17. 17

    The emergence of drug resistance to targeted cancer therapies: Clinical evidence by Sarmento-Ribeiro, Ana Bela, Scorilas, Andreas, Gonçalves, Ana Cristina, Efferth, Thomas, Trougakos, Ioannis P.

    Published in Drug resistance updates (01-12-2019)
    “…For many decades classical anti-tumor therapies included chemotherapy, radiation and surgery; however, in the last two decades, following the identification of…”
    Get full text
    Journal Article
  18. 18

    Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias by Gonçalves, Ana Cristina, Alves, Raquel, Sarmento-Ribeiro, Ana Bela

    “…Hematological neoplasias are among the most common cancers worldwide, and the number of new cases has been on the rise since 1990, reaching 1 [...]…”
    Get full text
    Journal Article
  19. 19

    Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies by Jorge, Joana, Neves, Joana, Alves, Raquel, Geraldes, Catarina, Gonçalves, Ana Cristina, Sarmento-Ribeiro, Ana Bela

    “…Lymphoid malignancies are a group of highly heterogeneous diseases frequently associated with constitutive activation of the nuclear factor kappa B (NF-κB)…”
    Get full text
    Journal Article
  20. 20